REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,066,000 | -59.1% | 7,500,000 | -46.4% | 0.03% | -63.0% |
| Q2 2023 | $14,826,000 | +140.8% | 14,000,000 | +180.0% | 0.07% | +135.5% |
| Q1 2023 | $6,157,500 | +2.6% | 5,000,000 | -23.1% | 0.03% | -29.5% |
| Q4 2022 | $5,999,500 | -45.0% | 6,500,000 | -35.0% | 0.04% | -33.3% |
| Q3 2022 | $10,900,000 | -0.8% | 10,000,000 | -25.9% | 0.07% | +22.2% |
| Q2 2022 | $10,986,000 | -24.7% | 13,500,000 | -12.9% | 0.05% | +35.0% |
| Q1 2022 | $14,580,000 | +6.5% | 15,500,000 | 0.0% | 0.04% | +73.9% |
| Q4 2021 | $13,688,000 | -20.9% | 15,500,000 | +3.3% | 0.02% | -32.4% |
| Q3 2021 | $17,301,000 | +18.1% | 15,000,000 | +20.0% | 0.03% | +3.0% |
| Q2 2021 | $14,646,000 | +85.9% | 12,500,000 | +78.6% | 0.03% | +43.5% |
| Q1 2021 | $7,880,000 | – | 7,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |